MDGL position history
The shares of Madrigal Pharmaceuticals (MDGL) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 1,787 shares, $935K, 0.14% of portfolio, New
- 2026 Q2: 1,787 shares, $960K, 0.13% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|